January 11, 2019
The National Institutes of Health will not decide whether to continue its long-term multimillion-dollar contract with the University of California, San Francisco to make “humanized mice” with organs taken from aborted babies until after it has completed its ongoing audit of all HHS-funded fetal tissue acquisitions and a comprehensive review of HHS-funded fetal tissue research.
In the meantime, NIH has given UCSF a 90-day extension on the contract.
The contract extension with UCSF was signed Dec. 4, 2018 and runs through March 5, 2019, according to the Federal Procurement Data System. It will pay the university $521,082.
“The contract remains on the 90-day extension to ensure continuity of service until the audit is completed and a final decision can be made about the contract,” the NIH said in a written statement provided in response to questions submitted by CNSNews.com.
“During the 90-day extension,” the NIH said, “the NIH Contracting Officer Representative can instruct UCSF to produce new mouse cohorts, obtain or engraft new fetal tissue, and/or start new in vitro or humanized mouse studies that are not already planned, if deemed scientifically necessary.”
This article was posted: Friday, January 11, 2019 at 6:42 am